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Background: Although cigarette smoking affects all biological systems of the human body including the gastrointestinal
tract, there is a lack of evidence regarding its effect on the severity of diarrhoeal disease and whether a dose–response
relationship exists. We therefore tested for the presence of specific causative pathogens for infectious diarrhoea, assessed
the independent effect of smoking on its severity and tested whether any dose–response relationship existed while
controlling for subjects’ age, sociodemographic characteristics and presence of causative pathogens in an urban setting in
Bangladesh.
Methods: A total of 20,757 patients aged 15 years and above with diarrhoea were enrolled into the Diarrhoeal Disease
Surveillance System, managed by the International Centre for Diarrhoeal Disease Research, Bangladesh, from 1993 to 2012.
We collected data on individuals’ current daily consumption of cigarettes and bidis (traditional hand-rolled cigarettes) and
conducted an ordered logistic regression to determine the effect of smoking on diarrhoeal disease severity and whether a
dose–response relationship exists.
Results: We identified 19 % of patients with diarrhoea as smokers, of whom 52 % smoked 1–9 cigarettes per day. While
97 % of smokers were male, 41 % were aged 15–30 years of age. Smokers were found to have a significantly lower
severity of diarrhoeal disease (OR: 0.92, 95 % CI: 0.85–0.99, p = 0.025) after adjusting for age, wealth quintile, illiteracy and
the presence of specific causative pathogens (Vibrio cholerae and Shigella). We observed no dose–response relationship
between the number of cigarettes smoked per day and disease severity when adjusting for the same covariates. Smokers
were more frequently infected with Shigella (7 vs. 6 %, p < 0.001) and less often with Vibrio cholerae (22 vs. 26 %,
p < 0.001) than their non-smoking counterparts.
Conclusions: The aetiology and severity of diarrhoeal disease differed between smokers and non-smokers in our sample.
However, we found no dose–response relationship between disease severity and the number of cigarettes smoked per
day.
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Despite increasing awareness of the health harms of
smoking, tobacco use remains highly prevalent in low
income countries [1–9]. The World Health Organization
estimates that one third of the global population aged
15 years and above are smokers and that 84 % of these* Correspondence: gfaruque@icddrb.org
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creativecommons.org/publicdomain/zero/1.0/live in developing countries [2, 3]. Cigarettes contain
nicotine, which is known to have a number of detrimen-
tal effects on a range of biological systems including the
respiratory, cardiovascular, gastrointestinal, renal ner-
vous, endocrine and metabolic systems [4–8]. Further-
more, previous work suggests that a dose–response
relationship exists between cigarette smoking and the se-
verity of chronic conditions such as ulcerative colitis,
gastroesophageal reflux disorder, peptic ulcer disease
and Crohn’s disease, in addition to the risk of developing
malignant tumours [8, 9]. Similar relationships have alsole distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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hand tobacco smoke [10-13].
Although diarrhoea represents the second leading
cause of childhood morbidity and mortality globally, it
also often affects other age groups including adults and
older people [14]. Vibrio cholerae and Shigella, both of
which have high pandemic potential, are the two most
important causative agents for diarrhoeal disease and
are considered major public health concerns in a num-
ber of countries [15–20]. The majority of studies on the
epidemiology of diarrhoeal disease have focused on pa-
tients’ age, the etiology and burden of disease, and spe-
cific outcomes, including mortality [15]. However, there
is currently a lack of evidence on individual-level deter-
minants of diarrhoeal disease, in particular health be-
haviours such as smoking. The International Centre for
Diarrhoeal Disease Research, Bangladesh (icddr,b) has
maintained a comprehensive Diarrhoeal Disease Sur-
veillance System (DDSS) since 1979 [21], which collects
prospective data on individuals presenting with diar-
rhoea to a large urban health centre in Dhaka. Data on
smoking behavior were recorded for all attending indi-
viduals aged 15 years and above as part of this surveil-
lance system. Using this data, the aim of the present
study were firstly to assess the distributions of causative
pathogens for diarrhoeal disease among smokers and
non-smokers, secondly, to assess the symptom profiles
of infectious diarrhoea cases among smokers and non-
smokers when stratified by the presence of different
causative pathogens, and, thirdly, to determine the inde-
pendent effects of smoking on disease severity while
controlling for patients’ age, sociodemographic charac-
teristics and the presence of specific causative patho-
gens and to test for the presence of a dose–response
relationship.
Methods
Study context and data collection
Dhaka Hospital, located in the capital city of Bangladesh,
was established in 1962 by icddr,b and has since provided
free medical care to all patients. The DDSS systematically
sampled 4 % of all attending patients from 1979 to 1995 and
2 % of patients since 1996 to adjust for a more than two-
fold increase in patient numbers. Using a structured ques-
tionnaire, the system collects information on infant and
young children’s feeding practices and the use of drug and
fluid therapy in the home, as well as patients’ clinical, epi-
demiological, etiologic, and demographic characteristics. We
extracted the relevant data, which covered the period from
1993 to 2012, from the DDSS archive. A total of 20,914 pa-
tients with diarrhoea aged 15 years and above were enrolled
into the surveillance system during this period. Of these,
20,757 were included in the analysis and 157 were excluded
because of missing data.Assessment of smoking status
As part of DDSS, current use of cigarettes or bidis (trad-
itional hand-rolled cigarettes) was recorded for each en-
rolled patient aged 15 years and above with diarrhoea, in
addition to the number smoked per day. Although data on
parental smoking behavior was collected for children under
15 years, this was not used in the present analysis. Current
smokers (number of cigarettes or bidis smoked per day ≥1)
were considered cases while non-smokers (number smoked
per day = 0) comprised the comparison group.
Laboratory methods
A fresh whole stool specimen was collected from each pa-
tient enrolled in the DDSS and examined in icddr,b’s cen-
tral laboratory in Dhaka. Each specimen was aliquoted
into three containers and submitted for routine screening
for common enteric pathogens including Vibrio cholerae,
Shigella spp., Salmonella spp., Campylobacter spp., Ent-
amoeba histolytica, Giardia lamblia [22], and rotavirus
[23] using standard laboratory methods.
The antimicrobial susceptibility of Shigella spp. and
Vibrio cholerae to different antimicrobial agents was
determined using the disk diffusion method (CLSI 2010)
employing commercial antimicrobial discs (Oxoid,
Basingstoke, United Kingdom). While we used ampicil-
lin (10 μg), mecillinum (25 μg), nalidixic acid (30 μg),
trimethoprim-sulfamethoxazole [(TMP-SXT)], (25 μg),
and ciprofloxacin (5 μg) antibiotic discs to test the sus-
ceptibility of Shigella, tetracycline (30 μg), (TMP-SXT)
(25 μg), erythromycin (15 μg), and ciprofloxacin (5 μg)
disks were used for Vibrio cholerae [24].
Data analysis
Patients’ sociodemographic and clinical characteristics, in-
cluding severity of diarrhoeal disease symptoms (mild,
moderately severe, severe or very severe), abdominal pain,
stool character (watery), length of hospitalisation (>24 h)
and distribution of enteric pathogens were compared be-
tween smokers and non-smokers using the chi-square test.
Diarrhoeal disease severity was scored using a 17-point
numerical scale based on the following clinical features:
duration of diarrhoea, number of stools passed in last 24 h,
number of occasions of vomiting in last 24 h, fever (°C), de-
hydration status and treatment received (described in
greater detail by Ruuska et.al.) [25]. Disease severity was
then classified as mild (≤6), moderately severe (7–9), severe
(10–12) or extremely severe (≥13). Duration of vomiting
was not used for scoring because of incomplete data.
Wealth quintiles were estimated using principal compo-
nent analysis based on household assets such as construc-
tion materials of the house and ownership of durable goods
including a fan, radio, television, cupboard, sanitary toilet
and a luxury or ordinary cot. Age was expressed as a binary
variable, with subjects categorised being 15–30 years or
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was used when estimating the family income. Other binary
variables were included to code for whether subjects habit-
ually boiled their drinking water and whether they had
taken antimicrobials before attending hospital.
Finally, we used an ordered logistic regression model
(proportional odds model) to assess the independent effects
of smoking on disease severity while controlling for age
and sociodemographic factors (wealth index and level
of education) and the presence of causative pathogens
(Shigella, and Vibrio cholerae) using STATA Version 12.
We performed an additional analysis by including a cat-
egorical variable for number of cigarettes smoked daily
(1 = 1–9, 2 = 10–19, 3 = ≥20) to determine any dose–re-
sponse relationship with diarrhoeal disease severity while
controlling for the same covariates. Given that 97 % of
smokers were male, female subjects were excluded from all
multivariate analyses. The strengths of association were de-
termined by estimating odds ratios (OR) and 95 % confi-
dence intervals (95 % CI) with p <0.05 considered to be
statistically significant.
Ethical statement
The DDSS of icddr,b is an ongoing programme of the
Dhaka Hospital which has been approved by the Research
Review Committee and the Ethical Review Committee of
icddr,b. Interviews took place only after obtaining verbal
consent from either patients themselves, or, where pa-
tients were aged 15 to 19 years, from both patients and
their parents or guardians, according to hospital policy.
The questionnaire recorded when consent was given. Pa-
tients were assured of the confidentiality of all personal
data collected from them and informed about its use for
research purposes and for improving patient care. TheTable 1 Socioeconomic characteristics of diarrhoea patients identifie
Indicators Smoker,
15–30 years 1630 (41
Above 30 years 2356 (59
Male sex 3874 (97
Monthly income ≤100 US$ 2752 (69
Small family size (≤5 mean) 2298 (58
Wealth quintile
Rich 591 (15)
Upper middle 720 (18)
Middle 799 (20)
Lower middle 918 (23)
Poor 958 (24)
Patient’s illiteracy 1897 (52
Boils drinking water 635 (16)
Administered antimicrobial therapy before attending the hospital 2258 (57
OR, Odds ratio; 95 % CI, 95 % Confidence interval. p values were calculated using thEthical Review Committee approved this method for
obtaining consent and is satisfied that patients participated
voluntarily, that their rights were not violated, and that
personal data were handled in a confidential manner by
the hospital staff.
Results
We found that 19 % (3986) of patients diagnosed with
diarrhoea were current smokers, 52 % of whom (2095)
smoked 1–9 cigarettes per day, 37 % (1464) 10–19 ciga-
rettes per day, and 11 % (427) 20 or more cigarettes per
day (data not shown). The vast majority of smokers were
male (97 %), 41 % were aged 15–30 years. A significantly
higher proportion of smokers were illiterate, had a
monthly household income of ≤100 US$ and were gen-
erally more socioeconomically disadvantaged when com-
pared with non-smokers (Table 1). Furthermore, while a
lower proportion of smokers boiled their drinking water,
the proportion using antimicrobials before attending
hospital was similar in both groups.
The overall proportion of smokers in 1993 was 26 %,
which gradually decreased to 16 % in 2003 and there-
after began to increase steadily (Fig. 1). The proportion
of teenage and young adult smokers also evolved over
time and began to decrease gradually from 2005 except
for a small rise in 2006 (Fig. 1).
Smokers were more frequently infected with Shigella
spp. and less often with Vibrio cholerae than their non-
smoking counterparts. The isolation rates of other com-
mon pathogens such as Salmonella spp., rotavirus, Ent-
amoeba histolytica, and Giardia lamblia were similar in
both groups (Table 2).
In terms of disease severity, a significantly higher pro-
portion of smokers had mild or moderate diseased as smokers and non-smokers
n = 3986 (%) Non-smoker, n = 16,771 (%) OR (95 % CI) p value
) 9566 (57) 0.52 (0.49, 0.56) <0.001
) 7205 (43) 1.92 (1.79, 2.06) <0.001
) 7767 (46) 40.10 (33.02, 48.74) <0.001
) 10,664 (64) 1.28 (1.19, 1.38) <0.001
) 10,268 (61) 0.86 (0.80, 0.93) <0.001
3557 (21) 0.65 (0.59, 0.71) <0.001
3417 (20) 0.86 (0.79, 0.94) <0.001
3317 (20) 1.02 (0.93, 1.11) 0.720
3307 (20) 1.22 (1.12, 1.32) <0.001
3173 (19) 1.36 (1.25, 1.47) <0.001
) 7328 (44) 1.17 (1.09, 1.25) <0.001
4019 (24) 0.60 (0.55, 0.66) <0.001
) 9646 (58) 0.97 (0.90, 1.04) 0.328
e chi-square test
Fig. 1 Yearly distribution of overall smokers and proportion of teenager and young adults smokers (1993–2012)
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ever, had severe symptoms (Table 3). The proportions of
patients with watery stool and of those hospitalised for
more than 24 h were significantly lower among smokers.
The proportions of abdominal pain was similar in both
groups (Table 3). Detailed pathogen-specific differences
in disease severity and other clinical characteristics be-
tween smokers and non-smokers are also shown in
Table 3.
Our univariate analysis showed that smokers had a
significantly lower severity of diarrhoeal disease than
non-smokers (OR: 0.92, 95 % CI: 0.85–0.99, p =
0.035). This significant association remained after ad-
justment for age, sociodemographic characteristics
and the presence of specific pathogens (OR: 0.92,
95 % CI: 0.85–0.99, p = 0.025) (Table 4). However, no
dose–response relationship was observed between the
number of cigarettes smoked per day and disease se-
verity (Table 5). Moreover, no differences in suscepti-
bility to different antimicrobials were found for
either Shigella spp. (ampicillin, mecillinam, ciproflox-
acin, TMP-SXT and nalidixic acid) or Vibrio cholerae
(ampicillin, tetracycline, erythromycin, TMP-SXT and
ciprofloxacin) (data not shown).Table 2 Distribution of common causative pathogens for diarrhoea
Pathogens Smoker, n = 3986 (%)
Vibrio cholerae 861 (22)
Shigella spp. 287 (7)
Salmonella spp. 99 (3)
Campylobacter spp. 186 (5)
Rotavirus 130 (3)
Entamoeba histolytica 81 (2)
Giardia lamblia 97 (3)
OR, Odds ratio; 95 % CI, 95 % Confidence interval. p values were calculated using thDiscussion
Despite global tobacco control efforts, tobacco use re-
mains widespread and the burden of smoking-related dis-
ease remains a major public health concern [2, 3, 26]. A
novel feature of the present study is that we analysed the
characteristics of smokers and non-smokers among a large
sample of patients who attended a diarrhoeal disease hos-
pital and determined the association between smoking
and severity of diarrhoeal disease. The smoking prevalence
among participants aged 15 years and above was 19 %,
compared with 14 % for the national population [27]. This
may be attributed to the specific characteristics of those
attending a large, specialised diarrhoeal disease facility in a
major urban centre.
Nicotine exposure can result in nausea and diarrhoea
related to increased intestinal motor activity [9] and can
increase gastric acid secretion, resulting in gastrointes-
tinal conditions such as dyspepsia [28]. While gastric
acid secretion is associated with the number of cigarettes
smoked a day and duration of smoking history [29], a
previous study reported that individuals who smoke
more than 20 cigarettes per day had a 1.55 times higher
risk of developing non-ulcer dyspepsia [30]. By contrast,
the present study found no dose–response relationshipamong smokers and non-smokers
Non-smoker, n = 16,771 (%) OR (95 % CI) p value
4409 (26) 0.77 (0.71, 0.84) <0.001
971 (6) 1.26 (1.10, 1.45) <0.001
343 (2) 1.22 (0.97, 1.54) 0.096
814 (5) 0.96 (0.81, 1.13) 0.649
612 (4) 0.90 (0.73, 1.09) 0.281
278 (2) 1.24 (0.96, 1.60) 0.100
364 (2) 1.13 (0.89, 1.43) 0.318
e chi-square test



















Sm; Non-sm; Sm; Non-sm; Sm; Non-sm; Sm; Non-sm; Sm; Non-sm; Sm; Non-sm; Sm; Non-sm; Sm; Non-sm;
3986 16,771 861 4409 287 971 99 343 186 814 130 612 81 278 97 364
Disease severity
Mild 537 (14) 1728 (10) 29 (3) 116 (3) 60 (21) 169 (17) 19 (19) 33 (10) 27 (15) 87 (11) 23 (18) 89 (15) 20 (25) 37 (13) 9 (9) 53 (15)
Moderately
severe
1627 (41) 6355 (38)* 200 (23) 910 (21) 161 (56) 483 (50) 43 (43) 162 (47)* 64 (34) 301 (37) 56 (43) 313 (51) 36 (44) 137 (49)* 40 (41) 120 (33)
Severe 1794 (45) 8484 (51)* 623 (72) 3317 (75) 64 (22) 312 (32)* 35 (35) 141 (41)* 95 (51) 424 (52) 50 (39) 202 (33) 24 (30) 101 (36)* 48 (50) 189 (52)
Extremely
severe
28 (1) 204 (1) 9 (1) 66 (2) 2 (1) 7 (1) 2 (2) 7 (2) 0 (0) 2 (0.2) 1 (1) 8 (1) 1 (1) 3 (1) 0 (0) 2 (1)
Abdominal
pain
2491 (63) 10,475 (63) 442 (51) 2398 (54) 236 (82) 746 (77) 65 (66) 231 (67) 106 (57) 500 (61) 81 (62) 355 (58) 51 (63) 194 (70) 56 (58) 232 (64)
Watery
stool
3643 (91) 15,788 (94)* 851 (99) 4386 (99)* 170 (59) 692 (71)* 91 (92) 324 (95) 171 (92) 780 (96)* 125 (96) 594 (97) 69 (85) 248 (89) 91 (94) 351 (96)
Hospitalization
>24 h
720/3839 (19) 3761/16,221 (23)* 260/836 (31) 1502 (35)* 43/278 (16) 189 (20) 25/95 (26) 89 (27) 34/184 (19) 165 (21) 20 (15) 117 (20) 14/80 (2) 63 (23) 16/96 (17) 78 (22)














Table 4 Univariate and multivariate associations between smoking and severity of diarrhoeal disease
Characteristics Unadjusted.
OR (95 % CI), p
Model 1;
OR (95 % CI), p
Model 2;
OR (95 % CI), p
Model 3;
OR (95 % CI), p
Model 4;
OR (95 % CI), p
Model 5;
OR (95 % CI) p
Smoking 0.92 (0.85-0.99) 0.035 0.95 (0.88-1.03) 0.239 0.89 (0.83-0.96) 0.004 0.92 (0.85-0.99) 0.025 0.89 (0.83-0.96) 0.004 0.92 (0.85-0.99) 0.025
Age -
15–30 years 1 1 1 1 1 1
Above 30 years 0.86 (0.79-0.95) 0.002 0.83 (0.78-0.89) <0.001 0.81 (0.76-0.87) <0.001 0.92 (0.85-0.99) 0.024 0.82 (0.76-0.88) <0.001 0.92 (0.85-0.99) 0.020
Wealth quintile - -
1st (rich) 1 - 1 1 1 1
2nd (upper middle) 1.27 (1.12-1.44) <0.001 - 1.24 (1.11-1.38) <0.001 1.20 (1.08-1.35) 0.001 1.24 (1.11-1.39) <0.001 1.21 (1.08-1.35) 0.001
3rd (middle) 1.60 (1.40-1.83) <0.001 - 1.40 (1.25-1.56) <0.001 1.31 (1.17-1.47) <0.001 1.41 (1.26-1.57) <0.001 1.32 (1.18-1.47) <0.001
4th (lower middle) 2.01 (1.75-2.30) <0.001 - 1.37 (1.22-1.54) <0.001 1.37 (1.22-1.54) <0.001 1.40 (1.25-1.57) <0.001 1.39 (1.24-1.56) <0.001
5th (poor) 1.75 (1.52-2.00) <0.001 - 1.26 (1.12-1.43) <0.001 1.32 (1.67-1.50) <0.001 1.32 (1.17-1.49) <0.001 1.36 (1.20-1.54) <0.001
Illiterate 1.84 (6.12-6.81) <0.001 - 1.41 (1.29-1.52) <0.001 1.40 (1.29-1.51) <0.001 1.43 (1.30-1.52) <0.001 1.39 (1.28-1.51) <0.001
Vibrio cholerae 5.61 (4.72-6.65) <0.001 - - 4.44 (4.05-4.86) <0.001 - 4.28 (3.90-4.69) <0.001
Shigella spp. 0.53 (0.45-0.61) <0.001 - - - 0.45 (0.40-0.52) <0.001 0.57 (0.50-0.66) <0.001
Only results for male subjects shown. Odds ratios (OR), 95 % confidence intervals (95 % CI) and p values, calculated using ordinal logistic regression, are shown for each model
Dependent variable: disease severity (0 =mild, 1 = moderately severe, 2 = severe, 3 = extremely severe)
Primary exposure: current smoker (0 = no, 1 = Yes)
Adjusting confounder/modifiers:
Model 1: Disease severity, Age (0 = 15–30 years)
Model 2: Model 1 +Wealth index (0 = rich), Illiteracy (0 = literacy)
Model 3: Model 2 + Vibrio cholerae (0 = no)
Model 4: Model 2 + Shigella spp. (0 = no)














Table 5 Dose–response relationship between number of cigarettes smoked per day and severity of diarrhoeal disease (multivariate
analysis)
Cigarettes smoked Unadjusted; OR (95 % CI) p Adjusted; OR (95 % CI) p
Non-smokers 1.00 1.00
1-9 sticks/day 0.89 (0.82-0.98) 0.024 0.87 (0.79-0.95) 0.005
10-19 sticks/day 0.97 (0.88-1.08) 0.876 0.98 (0.87-1.09) 0.467
≥20 sticks/day 0.88 (0.74-1.06) 0.736 0.93 (0.77-1.13) 0.456
All analyses limited among male; OR, Odds ratio; CI, Confidence interval; unadjusted and adjusted (models) p value was computed by ordinal logistic regression
Dependent variable: disease severity (0 =mild, 1 =moderately severe, 2 = severe, 3 = extremely severe)
Main exposure: Number of cigarettes smoked (0 = non-smokers, 1 = 1-9 sticks/day, 2 = 10-19 sticks/day, 3 = ≥20 sticks/day)
Adjusting confounder/modifiers:
Age (0 = 15-30 years), wealth index (0 = rich), illiteracy (0 = literacy), Vibrio cholerae (0 = no), Shigella spp. (0 = no)
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rhoeal disease severity. This may be because of the small
number of individuals in our sample who reported
smoking more than 20 cigarettes per day.
Smokers were more likely to be infected with Shigella
spp. and less likely to develop Vibrio cholerae infections
when compared with non-smokers. Given that produc-
tion of hydrochloric acid in the stomach may be elevated
in smokers, larger numbers of ingested Vibrio cholerae
may not survive and thus may require higher infective
dose (>105 organisms). By contrast, the infective dose of
Shigella spp. to allow it to pass through the gastric acid
barrier is as low as 10 organisms. Additionally, smoking
compromises leukocyte function (including neutrophils,
monocytes, T and B cells), thereby and increasing the
risk of infection [31]. This effect may also increase the
risk of shigellosis infection via mucosal membranes be-
cause of decreased humoral immune responses [32].
Smoking among women is highly stigmatised in
Bangladesh for cultural reasons, with the exception of a few
tribal groups [33]. This explains the fact that 97 % of
smokers in our sample were male. More than two thirds of
smokers were in the three lowest wealth quintiles. Low
earnings compounded by social disadvantage are strong de-
terminants of mental illness such as depression, which in
turn leads to adverse health behaviours such as smoking up-
take in adolescence. Although controversial, previous work
suggests that smokers may exploit the calming effects of
nicotine to reduce anxiety [34, 35]. Moreover, illiteracy and
lack of access to electronic media may lead to lower aware-
ness of the long term health consequences of smoking.
The proportion of subjects who habitually boiled their
drinking water was lower among smokers than non-
smokers in univariate analysis. Although this is an import-
ant predictor of diarrhoea, it can also be considered a proxy
indicator for socioeconomic status. This result is therefore
expected given that smokers are more likely to be socioeco-
nomically disadvantaged. Additionally, more than half of
the participants had received antimicrobials prior to coming
to hospital, which may be a concern given the potential for
antimicrobial resistance to develop. However, we found thatmost commercially available antimicrobials such as cipro-
floxacin (96 %), mecillinam (95 %) and ceftriaxone (100 %)
were effective against Shigella spp., and 100 % of Vibrio cho-
lerae isolates showed susceptibility to ciprofloxacin (data
not shown).
Significant differences in disease severity were found
between smokers and non-smokers presenting with diar-
rhoeal illnesses. These observations may be correlated
without a casual pathway because of the common symp-
tom profiles associated with different enteric pathogens.
While frequent consumption of contaminated food and
water may be the underlying cause of diarrhoeal disease
in our sample, differences in disease severity may have
also been a result of health behaviours such as calorie
restriction, which is more widespread among middle-
aged individuals. We were unable to evaluate these pos-
sible effects, however, because of a lack of data.
Study limitations
Given that the present study was conducted among pa-
tients presenting with diarrhoeal disease attending a spe-
cialised facility in an urban area, our results may not be
generalizable to the wider national population. There
was also a lack of retrospective data on lifetime smoking
behaviour which may have caused the effect of smoking
on disease severity to be underestimated. Furthermore,
lack of data prevented us from adjusting for the presence
of functional gastrointestinal disorders. Another concern
was the lack of data on the duration of vomiting when
determining disease severity scores. However, the study’s
strengths included the large data sample employed, the
low probability of bias of our systematic sampling
methods and the high laboratory performance for de-
tecting specific causative pathogens.
Conclusions
The distinct clinical and etiological patterns of diarrhoeal
disease observed in the present study suggest that smokers
in our sample differed from non-smokers. Despite the lim-
itations of the present study, our results contribute signifi-
cantly to the evidence base on the relationship between
Das et al. BMC Public Health  (2015) 15:646 Page 8 of 9smoking and diarrhoea and its public health implications.
Greater priority should be given by policy makers and
public health practitioners to implement tobacco control
programmes and restricting access to tobacco among the
general population, especially among teenagers and young
adults, to reduce the disease burden caused by both active
and passive smoking. Moreover, further in-depth research
is needed to explore the impact of smoking on diarrhoeal
illnesses of diverse aetiology.
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